JPRN-UMIN000034321
Completed
未知
A retrospective study of interstitial lung disease due to EGFR tyrosine kinase inhibitor and immune checkpoint inhibitor - NEJ040
Conditionsnon-small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- non-small cell lung cancer
- Sponsor
- Juntendo University
- Enrollment
- 235
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
POPLAR studyPulmonary hypertension, Interstitial lung diseaseD006976, D017563JPRN-jRCT1010230018Tsujino Ichizo250
Recruiting
Not Applicable
An Observational Cohort Study of Interstitial Lung Abnormalities (ILAs) in a Large Japanese Health Screening Population (Kumamoto ILA study in Japan: KILA-J)Progressive fibrosing interstitial lung diseases including idiopathic pulmonary fibrosisJPRN-UMIN000045149Department of Respiratory Medicine Kumamoto University Medical Sciences1,500
Completed
Not Applicable
A cohort study of idiopathic interstitial pneumonia in Shizuoka.JPRN-UMIN000015370Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
Completed
Not Applicable
Study of interstitial lung disease in primary antibody deficiencyD83.9J84.8Common variable immunodeficiency, unspecifiedOther specified interstitial pulmonary diseasesDRKS00000799niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)150
Recruiting
Not Applicable
Pulmonary involvement (interstitial lung disease of known etiology) in patients with Seropositive and ACPA positive Rheumatoid Arthritis (RA-ILD I and II)Early detection of lung involvement in RAM05.9M05.1J99.0Seropositive rheumatoid arthritis, unspecifiedRheumatoid lung diseaseDRKS00028871Boehringer Ingelheim Pharma GmbH & Co. KG200